---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-256102"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2022-10-03T23:59:59+00:00"
generated_at: "2026-06-23T06:08:34.925604+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD raises $7M via Series A Preferred from Rubric Capital, extends debt maturity to Oct 31

## Summary
- Issued 7,000 Series A Preferred shares to Rubric Capital Management for $7M gross proceeds; proceeds for working capital.
- Financing agreement maturity extended to Oct 31, 2022; further extension to Nov 30 possible with additional $7M equity raise.
- Issued warrants to Sixth Street lenders for 125,000 common shares at $0.01 exercise price, expiring Sep 30, 2032.
- Company continues strategic alternatives process to strengthen long-term financial position.
- Securities issued in private placement under Section 4(a)(2) and Regulation D; no registration rights granted.

## SEC filing metadata
- accession: 0001193125-22-256102
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2022-10-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000119312522256102/0001193125-22-256102-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000119312522256102/d378570d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-256102
- JSON: https://secwatch.observer/filing/0001193125-22-256102.json
- Plain text: https://secwatch.observer/filing/0001193125-22-256102.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.